Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups

Matthew Lloyd

Novo Nordisk Postdoctoral Research Fellow


My research aims to determine the molecular mechanisms by which readers of histone modifications confer circadian rhythmicity onto downstream metabolic pathways to control glucose and lipid homeostasis. Understanding these processes promises to unlock novel anti-obesity therapies.